Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Óskar Ö HálfdánarsonKatja FallMargret H OgmundsdottirSigrún H LundEiríkur SteingrímssonHelga M OgmundsdottirHelga ZoegaPublished in: Pharmacoepidemiology and drug safety (2018)
Our findings do not support a chemopreventive effect of PPI use on breast cancer, prostate cancer, or malignant melanoma.
Keyphrases